Frontlight ResearchEarly access
Trial site
The Fifth Affiliated Hospital of Guangzhou Medical University
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Chronic kidney disease2 trials
- Diffuse large B-cell lymphoma2 trials
- Liver and biliary tract cancer2 trials
- Acute myeloid leukaemia1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Neuroblastoma1 trial
- Peripheral artery disease1 trial
- and 2 more
- Phase
- Phase 23 trials
- Phase 1/22 trials
- Phase 32 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed3 trials
- Not yet recruiting3 trials
- Lead sponsor
- Sun Yat-sen University3 trials
- Guangdong Provincial People's Hospital2 trials
- Cascade Pharmaceuticals, Inc1 trial
- ChromX Health1 trial
- CSL Behring1 trial
- and 6 more
Running trials
Not yet recruiting
Not yet recruiting
Active, not recruiting
Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS)
Recruiting
Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL
Not yet recruiting
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
Recruiting
Recruiting
Recruiting
Active, not recruiting
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma2 recruiting
- Acute myeloid leukaemia1 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Peripheral artery disease1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026